JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.03% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.5% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Regal Rexnord
RRX
$11.5B
| $21.2M | ﹤0.01% |
186,696
-21,521
| -10% | -$2.74M |
|
1527
State Street SPDR S&P Homebuilders ETF
XHB
$1.58B
| $21.2M | ﹤0.01% |
387,384
-9,218
| -2% | -$555K |
|
1528
H&R Block
HRB
$6.87B
| $21.2M | ﹤0.01% |
599,881
-4,140
| -0.7% | -$128K |
|
1529
Cabot Corp
CBT
$4.46B
| $21.2M | ﹤0.01% |
331,986
+22,062
| +7% | +$1.51M |
|
1530
Phillips Edison & Co
PECO
$5.17B
| $21.1M | ﹤0.01% |
632,335
+271,223
| +75% | +$9.21M |
|
1531
Edgewell Personal Care
EPC
$1.32B
| $21.1M | ﹤0.01% |
611,608
+80,136
| +15% | +$2.88M |
|
1532
Crown Holdings
CCK
$13.1B
| $21.1M | ﹤0.01% |
229,007
+36,617
| +19% | +$3.91M |
|
1533
Lear
LEA
$8.07B
| $21.1M | ﹤0.01% |
167,589
+9,590
| +6% | +$1.26M |
|
1534
The Ensign Group
ENSG
$10.6B
| $21.1M | ﹤0.01% |
286,758
+73,268
| +34% | +$5.85M |
|
1535
Commault Systems
CVLT
$5.87B
| $21.1M | ﹤0.01% |
334,776
+116,888
| +54% | +$7.26M |
|
1536
Sunrun
RUN
$2.37B
| $21M | ﹤0.01% |
897,961
+82,400
| +10% | +$1.98M |
|
1537
KB Home
KBH
$3.42B
| $21M | ﹤0.01% |
737,050
+272,900
| +59% | +$8.71M |
|
1538
CALL
Walt Disney
DIS
$178B
| $20.9M | ﹤0.01% |
221,700
+137,200
| +162% | +$15.2M |
|
|
PARA
1539
PUT
DELISTED
Paramount Global Class B
PARA
| $20.9M | ﹤0.01% |
845,300
+300,000
| +55% | +$9.14M |
|
1540
Forward Air
FWRD
$658M
| $20.9M | ﹤0.01% |
226,733
+7,759
| +4% | +$719K |
|
1541
PUT
Emerson Electric
EMR
$91.4B
| $20.8M | ﹤0.01% |
261,800
+251,600
| +2,467% | +$22.2M |
|
1542
PUT
Starbucks
SBUX
$124B
| $20.8M | ﹤0.01% |
272,300
-75,300
| -22% | -$5.78M |
|
1543
Washington Trust Bancorp
WASH
$750M
| $20.8M | ﹤0.01% |
429,906
-27,761
| -6% | -$1.35M |
|
1544
PUT
EQT Corp
EQT
$33.8B
| $20.8M | ﹤0.01% |
604,000
+4,000
| +0.7% | +$165K |
|
1545
Bio-Rad Laboratories Class A
BIO
$9.68B
| $20.8M | ﹤0.01% |
41,964
+4,929
| +13% | +$2.57M |
|
|
LADR
1546
Ladder Capital
LADR
$1.25B
| $20.7M | ﹤0.01% |
1,964,397
+87,103
| +5% | +$988K |
|
|
VERV
1547
DELISTED
Verve Therapeutics
VERV
| $20.7M | ﹤0.01% |
1,354,638
+235,804
| +21% | +$3.65M |
|
1548
American Financial Group
AFG
$12B
| $20.7M | ﹤0.01% |
149,049
+215
| +0.1% | +$30.2K |
|
|
VRE
1549
DELISTED
Veris Residential
VRE
| $20.7M | ﹤0.01% |
1,561,643
-275,583
| -15% | -$4.26M |
|
|
CSR
1550
Centerspace
CSR
$925M
| $20.7M | ﹤0.01% |
253,366
+8,918
| +4% | +$781K |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.